Samrat Pharmachem Stock Screener | Share Price & Fundamental Analysis
SAMRATPH
Pharmaceuticals
Screen Samrat Pharmachem share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹222.10
▼
-6.55 (-2.86%)
Market Cap
₹72.33 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.02
EPS (TTM)
₹23.02
Dividend Yield
0.43%
Debt to Equity
0.13
52W High
₹410.15
52W Low
₹222.10
Operating Margin
2.00%
Profit Margin
0.69%
Revenue (TTM)
₹290.00
EBITDA
₹5.00
Net Income
₹2.00
Total Assets
₹122.00
Total Equity
₹72.00
Samrat Pharmachem Share Price History - Stock Screener Chart
Screen SAMRATPH historical share price movements with interactive charts. Analyze price trends and patterns.
Samrat Pharmachem Company Profile - Fundamental Screener
Screen Samrat Pharmachem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SAMRATPH shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE103E01016
Samrat Pharmachem Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SAMRATPH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 122 | 122 | 117 | 85 | 57 | 58 | 40 | 41 | 36 | 36 |
| Current Assets | 103 | 103 | 99 | 71 | 47 | 50 | 33 | 33 | 28 | 28 |
| Fixed Assets | 11 | 11 | 11 | 10 | 9 | 7 | 7 | 7 | 7 | 7 |
| Liabilities | ||||||||||
| Total Liabilities | 122 | 122 | 117 | 85 | 57 | 58 | 40 | 41 | 36 | 36 |
| Current Liabilities | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 72 | 65 | 63 | 47 | 30 | 24 | 20 | 19 | 15 | 14 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 69 | 62 | 60 | 44 | 27 | 21 | 17 | 15 | 12 | 11 |
Screen SAMRATPH income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 290 | 287 | 283 | 311 | 222 | 180 | 138 | 112 | 93 | 71 | 62 | 48 |
| Expenses | 285 | 276 | 279 | 287 | 198 | 170 | 131 | 108 | 87 | 67 | 61 | 46 |
| EBITDA | 5 | 11 | 4 | 24 | 25 | 9 | 7 | 4 | 6 | 4 | 1 | 2 |
| Operating Profit % | 2.00% | 4.00% | 1.00% | 8.00% | 11.00% | 5.00% | 5.00% | 3.00% | 6.00% | 5.00% | 2.00% | 2.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 3 | 10 | 3 | 23 | 24 | 7 | 6 | 2 | 5 | 3 | 0 | 1 |
| Tax | 1 | 3 | 0 | 6 | 6 | 2 | 2 | 1 | 2 | 1 | 0 | 0 |
| Net Profit | 2 | 7 | 2 | 17 | 17 | 5 | 4 | 2 | 3 | 2 | 0 | 0 |
| EPS | 5.10 | 23.02 | 7.00 | 53.83 | 55.62 | 17.26 | 13.71 | 4.97 | 10.41 | 5.68 | 0.97 | 1.02 |
Samrat Pharmachem Cash Flow Screener - Liquidity Fundamentals
Screen SAMRATPH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -10 | 9 | -9 | 18 | 5 | -1 | 2 | 0 | -3 | 0 |
| Investing Activities | 0 | 0 | -3 | -1 | -3 | -2 | 2 | -2 | 1 | -2 |
| Financing Activities | 1 | -11 | 10 | -2 | -2 | 2 | -4 | 2 | 1 | 2 |
| Net Cash Flow | -10 | -2 | -3 | 15 | 0 | -1 | 1 | -1 | -1 | 0 |
Screen SAMRATPH shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 49.09% | 49.09% | 49.09% | 48.64% | 48.64% | 48.95% | 49.09% | 48.64% |
| FII Holding | 3.24% | 0.00% | 3.24% | 3.24% | 3.24% | 3.24% | 3.24% | 0.00% |
| DII Holding | 0.00% | 3.24% | 0.00% | 0.22% | 0.22% | 0.22% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 41.58% | 41.64% | 41.73% | 41.69% | 40.79% | 41.34% | 41.95% | 38.48% |
| Other Holding | 6.09% | 6.04% | 5.95% | 6.22% | 7.11% | 6.25% | 5.72% | 12.88% |
| Shareholder Count | 6,785 | 6,752 | 6,699 | 7,478 | 7,169 | 6,984 | 6,844 | 8,039 |
Samrat Pharmachem Dividend Screener - Share Yield Analysis
Screen SAMRATPH dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹1.00 | 0.43% |
| 2024-March | ₹1.00 | 0.32% |
| 2023-March | ₹1.00 | 0.30% |
| 2022-March | ₹1.00 | 0.28% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Samrat Pharmachem Index Membership - Market Screener Classification
Screen SAMRATPH by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Samrat Pharmachem Market Events Screener - Corporate Actions
Screen SAMRATPH market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.00 /share | -18.51% | ||
| Dividend | ₹ 1.00 /share | -18.65% | ||
| Dividend | ₹ 1.00 /share | 76.20% | ||
| Annual General Meeting | NA | 48.09% | ||
| Dividend | ₹ 1.00 /share | 162.00% | ||
| Annual General Meeting | NA | -20.77% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -14.06% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 0.67% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 24.89% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -9.48% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -16.31% |
Samrat Pharmachem Competitors Screener - Peer Comparison
Screen SAMRATPH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,850 | 40.53 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,395 | 69.57 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,005 | 60.33 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,213 | 22.48 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,073 | 18.68 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 96,814 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,800 | 18.37 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 92,086 | 50.91 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,340 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,494 | 27.88 | 13,458 | 3.70% | 2,216 | 49.80 |
Samrat Pharmachem Company Announcements - News Screener
Screen SAMRATPH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-02 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held Today | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-27 | Corporate Action-Board approves Dividend | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-26 | Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended September 30 2025 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-04 | Reg. 34 (1) Annual Report. | View |
| 2025-09-04 | Book Closure: Friday September 19 2025 To Thursday September 25 2025 (Both Days Inclusive) | View |
| 2025-09-04 | Record Date - Thursday September 18 2025 | View |
| 2025-09-04 | Notice Of 33Rd Annual General Meeting Of Samrat Pharmachem Limited On Thursday September 25 2025 | View |
| 2025-08-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-13 | Un-Audited Financial Results For The Quarter Ended June 30 2025 | View |
| 2025-08-13 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-07-25 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-07-18 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-07-16 | Announcement under Regulation 30 (LODR)-Change in Management | View |